Your Article Summary
Migrainous Vertigo Responsive to Intravenous Methylprednisolone: Case Reports
Headache: The Journal of Head and Face Pain, 06/26/09
Prakash S et al. - Migrainous vertigo (MV) is a newer evolving concept in which vertigo is causally related to migraine. The authors report 4 patients with MV. Episodes of severe MV of more than 1-day duration were successfully terminated by intravenous methylprednisolone (IV MPS) in 2 patients. Two other patients who had attacks of MV almost daily also showed complete response to IV MPS.
Related Articles
Nystagmus during Attacks of Vestibular Migraine: An Aid in Diagnosis
Audiology & Neuro-Otology, 11/06/09
Relevance Score: 67%
Vertigo: Epidemiologic Aspects
Seminars in Neurology, 10/22/09
Relevance Score: 65%
Bilateral Vestibulopathy: Clinical, Diagnostic, and Genetic Considerations
Seminars in Neurology, 11/02/09
Relevance Score: 64%
Vestibular Neuritis
Seminars in Neurology, 10/30/09
Relevance Score: 64%
Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09
Relevance Score: 48%
Today in Headache...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical observation on tuina therapy for cervicogenic headache
Journal of Acupuncture and Tuina Science, 12/09/09
Association between Restless Legs Syndrome and Migraine
Journal of Neurology, Neurosurgery, and Psychiatry , 12/09/09
Rupture of Middle Fossa Arachnoid Cyst Simulating New-Onset Migraine With Aura
Headache: The Journal of Head and Face Pain, 12/08/09

See Latest Articles